Other clinically relevant outcomes
| Outcome | Number of studies | Number of patients | RR | CI | WMD | CI |
|---|---|---|---|---|---|---|
| Patients who did not revisit hospital | 4 | 5314 | 1.10* | (1.03 to 1.17)† | ||
| Hospital stay (after readmission) | 2 | 803 | −0.57 | (−5.32 to 4.17)‡ | ||
| Readmission per patient | 3 | 1370 | −0.12 | (−0.24 to 0.01)‡ | ||
| ED visit per patient | 2 | 4342 | −0.15 | (−0.53 to 0.23)‡ | ||
| Patients with ADE | 3 | 1401 | 0.94 | (0.75 to 1.20)‡ |
*RR is >1 when the intervention increased the number of patients who did not revisit the hospital (ie, it showed success).
†p<0.01.
‡p>0.05.
ADE, adverse drug event; ED, emergency department; RR, risk ratio; WMD, weighted mean difference.